Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085]
Mod Pathol. 2023 Jun;36(6):100212.
doi: 10.1016/j.modpat.2023.100212.
Epub 2023 May 12.
1 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, British Columbia, Canada.
2 Department of Pathology, University of Turku, Turku University Hospital, Turku, Finland.
3 Department of Molecular Oncology, University of British Columbia, Vancouver, British Columbia, Canada.
4 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Dalhousie University, Halifax, Canada.
5 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, McGill University, Montreal, Canada.
6 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of Toronto, Toronto, Canada.
7 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, McMaster University, Hamilton, Ontario, Canada.
8 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of Manitoba, Winnipeg, Canada.
9 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of Montreal, Montreal, Quebec, Canada.
10 Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
11 Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
12 Department of Pathology, University of Toronto, Toronto, Ontario, Canada.
13 Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada.
14 Department of Pathology, Laval University, Quebec City, Quebec, Canada.
15 Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada.
16 Imagia Canexia Health, Inc., Vancouver, British Columbia, Canada.
17 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Laval University, Quebec City, Quebec, Canada.
18 Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
19 Department of Molecular Oncology, University of British Columbia, Vancouver, British Columbia, Canada; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Imagia Canexia Health, Inc., Vancouver, British Columbia, Canada.
20 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: jessica.mcalpine@vch.ca.